Progress and Perspective of CRISPR-Cas9 Technology in Translational Medicine.

clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR-Cas9) gene regulation gene therapy translational medicine

Journal

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ISSN: 2198-3844
Titre abrégé: Adv Sci (Weinh)
Pays: Germany
ID NLM: 101664569

Informations de publication

Date de publication:
09 2023
Historique:
revised: 29 03 2023
received: 09 01 2023
medline: 6 9 2023
pubmed: 25 6 2023
entrez: 25 6 2023
Statut: ppublish

Résumé

Translational medicine aims to improve human health by exploring potential treatment methods developed during basic scientific research and applying them to the treatment of patients in clinical settings. The advanced perceptions of gene functions have remarkably revolutionized clinical treatment strategies for target agents. However, the progress in gene editing therapy has been hindered due to the severe off-target effects and limited editing sites. Fortunately, the development in the clustered regularly interspaced short palindromic repeats associated protein 9 (CRISPR-Cas9) system has renewed hope for gene therapy field. The CRISPR-Cas9 system can fulfill various simple or complex purposes, including gene knockout, knock-in, activation, interference, base editing, and sequence detection. Accordingly, the CRISPR-Cas9 system is adaptable to translational medicine, which calls for the alteration of genomic sequences. This review aims to present the latest CRISPR-Cas9 technology achievements and prospect to translational medicine advances. The principle and characterization of the CRISPR-Cas9 system are firstly introduced. The authors then focus on recent pre-clinical and clinical research directions, including the construction of disease models, disease-related gene screening and regulation, and disease treatment and diagnosis for multiple refractory diseases. Finally, some clinical challenges including off-target effects, in vivo vectors, and ethical problems, and future perspective are also discussed.

Identifiants

pubmed: 37356052
doi: 10.1002/advs.202300195
pmc: PMC10477906
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2300195

Subventions

Organisme : Key Research and Development Plan of Zhejiang Province "Spearhead"
ID : 2022C03007
Organisme : Wenzhou Major Science and Technology Innovation Tackling Project
ID : 2020ZY0036
Organisme : Zhejiang Provincial Natural Science Foundation of China
ID : LGF22C100003
Organisme : Wenzhou high-level innovation team : Development and application team of functional liver cancer-on-a-chip program of Wenzhou Institute, University of Chinese Academy of Sciences
ID : WIUCASQD2021012

Informations de copyright

© 2023 The Authors. Advanced Science published by Wiley-VCH GmbH.

Références

Ann Neurosci. 2011 Jan;18(1):25-8
pubmed: 25205916
Nat Cell Biol. 2020 Mar;22(3):321-331
pubmed: 32123335
Biomaterials. 2020 Sep;252:120094
pubmed: 32422495
Invest Ophthalmol Vis Sci. 2016 Jul 01;57(8):3698-707
pubmed: 27403998
J Exp Clin Cancer Res. 2022 Jan 15;41(1):24
pubmed: 35033172
Nat Rev Mol Cell Biol. 2019 Aug;20(8):490-507
pubmed: 31147612
Mol Ther Oncolytics. 2018 Oct 18;11:75-89
pubmed: 30505938
Mol Ther. 2019 Apr 10;27(4):735-746
pubmed: 30803822
Nat Methods. 2013 Oct;10(10):977-9
pubmed: 23892898
Sci Transl Med. 2020 Aug 26;12(558):
pubmed: 32848096
Int J Biol Markers. 2018 May;33(2):215-221
pubmed: 29707994
Adv Sci (Weinh). 2023 Sep;10(25):e2300195
pubmed: 37356052
Mol Ther. 2022 Jan 5;30(1):54-74
pubmed: 34678511
Redox Biol. 2021 Jul;43:102006
pubmed: 34030117
Nat Rev Genet. 2001 Oct;2(10):780-90
pubmed: 11584294
Nat Med. 2019 Mar;25(3):423-426
pubmed: 30778239
Adv Mater. 2019 Aug;31(33):e1902575
pubmed: 31215123
Lancet. 2018 Aug 25;392(10148):685-697
pubmed: 30049419
Nature. 2015 Apr 9;520(7546):186-91
pubmed: 25830891
Biomaterials. 2018 Jul;171:207-218
pubmed: 29704747
Expert Rev Anticancer Ther. 2016 Jun;16(6):653-60
pubmed: 27010977
Nat Protoc. 2015 Nov;10(11):1842-59
pubmed: 26492140
Nature. 2021 Jul;595(7866):295-302
pubmed: 34079130
Methods. 2017 May 15;121-122:16-28
pubmed: 28351759
J Clin Invest. 2019 Mar 1;129(3):972-987
pubmed: 30688657
Nature. 2015 Jan 29;517(7536):583-8
pubmed: 25494202
Cell Physiol Biochem. 2017;44(6):2322-2336
pubmed: 29258089
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
Cell Stem Cell. 2018 Feb 1;22(2):171-176.e5
pubmed: 29290616
Nat Rev Genet. 2010 Sep;11(9):636-46
pubmed: 20717154
Annu Rev Med. 2019 Jan 27;70:273-288
pubmed: 30477394
ACS Synth Biol. 2017 Feb 17;6(2):211-216
pubmed: 27718551
Biotechnol Bioeng. 2021 May;118(5):2053-2066
pubmed: 33615437
Nat Rev Mol Cell Biol. 2016 Jan;17(1):5-15
pubmed: 26670017
J Cell Mol Med. 2019 Sep;23(9):6072-6084
pubmed: 31264792
Annu Rev Immunol. 2008;26:677-704
pubmed: 18173375
Theranostics. 2021 Oct 11;11(20):9833-9846
pubmed: 34815789
Clin Cancer Res. 2019 Apr 15;25(8):2523-2536
pubmed: 30538112
Science. 1995 Dec 15;270(5243):1811-5
pubmed: 8525373
Nat Rev Genet. 2015 May;16(5):299-311
pubmed: 25854182
Nat Med. 2022 Jan;28(1):31-38
pubmed: 35058619
J Natl Cancer Inst. 1990 Feb 21;82(4):267-76
pubmed: 2405170
Cell. 2016 May 19;165(5):1255-1266
pubmed: 27160350
Neurology. 2021 Dec 14;97(24):1111-1119
pubmed: 34663645
Emerg Microbes Infect. 2020 Dec;9(1):1682-1691
pubmed: 32643563
Cell. 2016 Sep 22;167(1):233-247.e17
pubmed: 27662091
Nat Med. 2018 Aug;24(8):1216-1224
pubmed: 30082871
Nat Biotechnol. 2016 Jun;34(6):631-3
pubmed: 27111720
Small. 2022 Sep;18(36):e2106580
pubmed: 35396770
Adv Mater. 2022 Feb;34(6):e2107434
pubmed: 34693571
N Engl J Med. 2021 Jan 21;384(3):252-260
pubmed: 33283989
Mol Ther. 2016 Mar;24(3):499-507
pubmed: 26607397
Nucleic Acids Res. 2016 May 19;44(9):e85
pubmed: 26850641
Nat Protoc. 2013 Nov;8(11):2180-96
pubmed: 24136345
Nat Biotechnol. 2008 Jul;26(7):808-16
pubmed: 18587387
EMBO J. 2003 Apr 15;22(8):1868-77
pubmed: 12682019
Nat Genet. 2021 Apr;53(4):511-520
pubmed: 33649594
Genome Res. 2019 Sep;29(9):1442-1452
pubmed: 31467027
Trends Biotechnol. 2013 Jul;31(7):397-405
pubmed: 23664777
Lancet Haematol. 2022 Oct;9(10):e776-e785
pubmed: 36174640
Nature. 2016 Nov 17;539(7629):384-389
pubmed: 27820943
Nat Protoc. 2018 Feb;13(2):358-376
pubmed: 29370156
Nat Med. 2020 Apr;26(4):459-461
pubmed: 32284618
Science. 2019 Sep 27;365(6460):1409-1413
pubmed: 31604268
Hum Mol Genet. 2022 May 19;31(10):1622-1634
pubmed: 34875064
Front Genet. 2019 Jan 07;9:691
pubmed: 30687381
Nat Methods. 2015 Dec;12(12):1143-9
pubmed: 26501517
Science. 2020 Apr 17;368(6488):290-296
pubmed: 32217751
Stem Cells Transl Med. 2018 Aug;7(8):615-624
pubmed: 29737632
Nat Commun. 2019 Oct 15;10(1):4681
pubmed: 31615983
Nat Biotechnol. 2020 Apr;38(4):471-481
pubmed: 32042170
Nat Biotechnol. 2014 Sep;32(9):941-6
pubmed: 24952903
Trends Mol Med. 2021 Jun;27(6):616-617
pubmed: 33836968
Nat Methods. 2016 Oct;13(10):868-74
pubmed: 27595405
Theranostics. 2020 Mar 15;10(10):4374-4382
pubmed: 32292501
J Thorac Cardiovasc Surg. 2022 Apr;163(4):1479-1490.e5
pubmed: 32682583
Anal Bioanal Chem. 2018 May;410(12):2889-2900
pubmed: 29546544
J Gen Virol. 2015 Aug;96(8):2381-2393
pubmed: 25854553
Brief Bioinform. 2020 Sep 25;21(5):1609-1627
pubmed: 31686105
Nat Methods. 2020 Nov;17(11):1093-1096
pubmed: 33020655
J Control Release. 2020 May 10;321:654-668
pubmed: 32114092
Theranostics. 2018 Jan 1;8(1):237-255
pubmed: 29290805
Mol Ther Nucleic Acids. 2015 Nov 17;4:e264
pubmed: 26575098
Cells. 2019 Apr 30;8(5):
pubmed: 31052294
Nat Biomed Eng. 2021 Jul;5(7):643-656
pubmed: 34272525
Am J Respir Crit Care Med. 2018 Sep 1;198(5):599-609
pubmed: 29924937
Cell. 2022 May 12;185(10):1764-1776.e12
pubmed: 35472302
Oncogene. 2022 Jan;41(2):268-279
pubmed: 34728806
Chem Soc Rev. 2014 Sep 21;43(18):6570-97
pubmed: 24792930
Anal Chem. 2018 Feb 6;90(3):2193-2200
pubmed: 29260561
Annu Rev Med. 2017 Jan 14;68:139-152
pubmed: 27860544
ACS Synth Biol. 2018 Mar 16;7(3):807-813
pubmed: 29486117
Nat Biotechnol. 2010 Aug;28(8):839-47
pubmed: 20601939
J Clin Invest. 2016 Aug 1;126(8):3130-44
pubmed: 27454297
Nat Rev Cancer. 2022 Nov;22(11):625-639
pubmed: 36064595
J Cell Mol Med. 2020 Apr;24(7):3766-3778
pubmed: 32096600
J Control Release. 2015 May 10;205:120-7
pubmed: 25553825
Nat Rev Microbiol. 2021 Jan;19(1):55-71
pubmed: 32887946
Nature. 2017 Nov 23;551(7681):464-471
pubmed: 29160308
Cell. 2003 Jun 13;113(6):673-6
pubmed: 12809598
Cell. 2013 Feb 28;152(5):1173-83
pubmed: 23452860
Development. 2017 Aug 1;144(15):2719-2729
pubmed: 28765213
Nat Rev Clin Oncol. 2019 Jun;16(6):372-385
pubmed: 30837712
Nature. 2018 Feb 15;554(7692):387-391
pubmed: 29414941
N Engl J Med. 2018 Jul 05;379(1):22-31
pubmed: 29972757
Gastroenterology. 2022 Oct;163(4):1053-1063.e7
pubmed: 35803312
Clin Cancer Res. 2021 May 15;27(10):2764-2772
pubmed: 33627493
Nat Biotechnol. 2020 Dec;38(12):1431-1440
pubmed: 32601430
J Mater Chem B. 2020 May 27;8(20):4369-4386
pubmed: 32364557
J Biotechnol. 2015 Aug 20;208:44-53
pubmed: 26003884
Nature. 2005 Jun 9;435(7043):834-8
pubmed: 15944708
Mol Cancer. 2022 Feb 21;21(1):57
pubmed: 35189910
Mol Ther. 2017 Aug 2;25(8):1782-1789
pubmed: 28527722
Trends Biotechnol. 2019 Jan;37(1):38-55
pubmed: 30177380
Neuron. 2017 Nov 15;96(4):755-768.e5
pubmed: 29056297
Trends Biotechnol. 2021 Sep;39(9):853-856
pubmed: 33342557
Drug Deliv. 2018 Nov;25(1):1234-1257
pubmed: 29801422
Nucleic Acids Res. 2017 Jul 27;45(13):7897-7908
pubmed: 28575452
Adv Drug Deliv Rev. 2021 Sep;176:113891
pubmed: 34324887
Nature. 2016 Apr 20;533(7603):420-4
pubmed: 27096365
Dis Model Mech. 2021 Jul 1;14(7):
pubmed: 34160014
Cell. 2019 Jan 10;176(1-2):377-390.e19
pubmed: 30612741
Nature. 2021 Jan;589(7843):608-614
pubmed: 33408413
Cell. 2022 Jul 21;185(15):2806-2827
pubmed: 35798006
Nucleic Acids Res. 2022 Jul 8;50(12):6687-6701
pubmed: 35713529
Front Genet. 2021 Apr 06;12:627050
pubmed: 33889176
Transl Neurodegener. 2022 Sep 15;11(1):41
pubmed: 36109806
Nat Rev Nephrol. 2022 May;18(5):277-293
pubmed: 35173348
Sci Transl Med. 2019 Apr 24;11(489):
pubmed: 31019024
Chromosome Res. 2015 Feb;23(1):43-55
pubmed: 25596827
Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9591-6
pubmed: 24927590
Cell. 2014 Oct 9;159(2):440-55
pubmed: 25263330
Nat Med. 2022 Aug;28(8):1573-1580
pubmed: 35922667
Blood. 2022 Feb 3;139(5):748-760
pubmed: 34587248
Gene. 2019 Mar 1;687:193-199
pubmed: 30447346
Cell Mol Immunol. 2021 Mar;18(3):566-578
pubmed: 33473192
Nature. 2008 Apr 3;452(7187):548-52
pubmed: 18385728
Mol Cancer. 2022 Mar 25;21(1):85
pubmed: 35337340
Annu Rev Cell Dev Biol. 2007;23:175-205
pubmed: 17506695
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Cell. 2014 Jun 5;157(6):1262-1278
pubmed: 24906146
Semin Cancer Biol. 2019 Apr;55:106-119
pubmed: 29673923
Protein Cell. 2017 May;8(5):379-393
pubmed: 28116670
Nat Med. 2020 May;26(5):732-740
pubmed: 32341578
Angew Chem Int Ed Engl. 2017 Jan 19;56(4):1059-1063
pubmed: 27981708
Lancet. 2010 Dec 11;376(9757):2018-31
pubmed: 21131035
Nat Biotechnol. 2013 Sep;31(9):822-6
pubmed: 23792628
Cell. 2014 Oct 23;159(3):647-61
pubmed: 25307932
Science. 2014 Nov 28;346(6213):1258096
pubmed: 25430774
Sci Rep. 2015 Nov 05;5:16277
pubmed: 26538064
Cancer Res. 2020 Apr 15;80(8):1748-1761
pubmed: 32054768
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Sci Rep. 2017 Jun 23;7(1):4159
pubmed: 28646206
J Clin Invest. 2014 Oct;124(10):4154-61
pubmed: 25271723
Nucleic Acids Res. 2016 Nov 16;44(20):9555-9564
pubmed: 27733506
Nat Rev Dis Primers. 2016 Oct 20;2:16080
pubmed: 27775730
Mol Ther Methods Clin Dev. 2020 Nov 26;20:258-275
pubmed: 33473359
Sci Adv. 2020 Aug 19;6(34):eaba5614
pubmed: 32875106
Mol Ther. 2016 Mar;24(3):488-98
pubmed: 26581162
Gene. 2022 Jun 20;828:146477
pubmed: 35398175
Science. 2020 Sep 25;369(6511):
pubmed: 32973003
Cell Mol Life Sci. 2021 Jul;78(13):5415-5425
pubmed: 34047803
Cell. 2018 May 3;173(4):989-1002.e13
pubmed: 29606351
Mol Cancer. 2022 Mar 18;21(1):78
pubmed: 35303871
Trends Cell Biol. 2014 Feb;24(2):108-17
pubmed: 24094932
Prog Retin Eye Res. 2014 Nov;43:108-28
pubmed: 25124745
Invest Ophthalmol Vis Sci. 2021 Sep 2;62(12):7
pubmed: 34499703
J Bacteriol. 1987 Dec;169(12):5429-33
pubmed: 3316184
Nat Biotechnol. 2018 Oct;36(9):829-838
pubmed: 30188539
Nucleic Acids Res. 2016 Jul 8;44(12):5615-28
pubmed: 26969735
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
J Clin Microbiol. 2019 Mar 28;57(4):
pubmed: 30429256
Nat Biomed Eng. 2018 Jun;2(6):377-391
pubmed: 31011197
Nat Rev Immunol. 2018 Mar;18(3):153-167
pubmed: 28990585
Sci Rep. 2020 Jun 25;10(1):10321
pubmed: 32587263
Cardiovasc Res. 2020 Apr 1;116(5):894-907
pubmed: 31584620
J Genet Genomics. 2018 Dec 20;45(12):681-684
pubmed: 30598393
Circulation. 2020 Jan 7;141(1):67-79
pubmed: 31779484
Cell. 2013 Sep 12;154(6):1380-9
pubmed: 23992846
J Biotechnol. 2020 Jan 20;308:1-9
pubmed: 31751596
Cell Stem Cell. 2013 Dec 5;13(6):653-8
pubmed: 24315439
Mol Cancer. 2022 Feb 7;21(1):38
pubmed: 35130925
Cell. 2020 Apr 2;181(1):136-150
pubmed: 32243786
Nat Rev Mol Cell Biol. 2019 Nov;20(11):698-714
pubmed: 31263220
Mol Ther. 2020 Feb 5;28(2):441-451
pubmed: 31882321
Annu Rev Physiol. 1988;50:483-508
pubmed: 3288102

Auteurs

Ruixuan Zheng (R)

Joint Centre of Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.
Division of Pulmonary Medicine, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.
Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.

Lexiang Zhang (L)

Joint Centre of Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.
Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.
Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health); Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325000, P. R. China.

Rokshana Parvin (R)

Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health); Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325000, P. R. China.

Lihuang Su (L)

Joint Centre of Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.
Division of Pulmonary Medicine, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.
Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.

Junjie Chi (J)

Joint Centre of Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.
Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.

Keqing Shi (K)

Joint Centre of Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.
Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.

Fangfu Ye (F)

Joint Centre of Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.
Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health); Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325000, P. R. China.
Beijing National Laboratory for Condensed Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, 100190, P. R. China.

Xiaoying Huang (X)

Joint Centre of Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.
Division of Pulmonary Medicine, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.
Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P. R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH